RxDoctor Payments Data

Clinton Washington, MD

Family Medicine · Smithville, MSNPI 1437163763

Payments from drug & device makers

$2,702in general payments, 2019–2025

Across 171 payments — averaging $15.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$531
  • AbbVie$426
  • Boehringer Ingelheim$261
  • Novo Nordisk$223
  • Pfizer$223
  • AstraZeneca$208
  • plus $831 from 17 others

What the payments were for

  • Food & beverage$2,702100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,702 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,202
Medicare patients
39
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide116$140,147
EliquisApixaban96$79,462
FarxigaDapagliflozin Propanediol82$64,223
JanuviaSitagliptin Phosphate53$54,702
MounjaroTirzepatide39$41,330
JardianceEmpagliflozin49$31,534
Tresiba Flextouch U-100Insulin Degludec34$24,702
Tresiba Flextouch U-200Insulin Degludec11$18,689
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp49$17,487
LinzessLinaclotide26$16,276
TrulicityDulaglutide17$15,973
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$11,924
XareltoRivaroxaban26$11,733
Imatinib Mesylate11$7,663
Gabapentin318$6,557

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog Mix 70-30$223$144,132134 claims
PfizerEliquis$223$79,46296 claims
AstraZenecaFarxiga, Symbicort$208$68,74996 claims
Lilly USA, LLCMounjaro, Trulicity$531$57,30356 claims
MerckJanuvia$141$54,70253 claims
Boehringer IngelheimJardiance$261$31,53449 claims
AbbVieLinzess, Lumigan$426$19,30537 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Smithville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →